Table 1.
Characteristics | (n = 18) |
---|---|
Age (years), median (range) | 55 (30–73) |
Gender F/M | 10/8 |
Patient with NF2 germline mutation | 4 |
Patients with multiple growing locations | 6 |
Number of growing tumors | 32 |
KPS, n (%) | |
90–100 | 4 (22) |
70–80 | 11 (61) |
<70 | 3 (17) |
Previous surgery, n (%) | |
One | 2 (11) |
Multiple | 16 (89) |
Previous radiotherapy or radiosurgery, n (%) | |
None | 1 (6) |
One | 8 (44) |
Multiple | 9 (50) |
Previous chemotherapy, n (%) | |
Yes | 4 (22) |
No | 14 (78) |
WHO grade, n (%) | |
WHO grade I | 1 (5%) |
WHO grade II | 10 (55%) |
WHO grade III | 7 (40%) |
Abbreviation: KPS, Karnofsky Performance Status.